WHO creates manual to deal with vaccine critics, adverse effects
The World Health Organization (WHO) has released a manual instructing governments on how to stem criticism over vaccines.

Mike Campbell

January 13, 2023

The World Health Organization (WHO) has released a manual instructing governments on how to stem criticism over vaccines.

WHO creates manual to deal with vaccine critics, adverse effects

The step-by-step guide tells federal agencies how to explain emerging data and adverse effects to maintain vaccine confidence. 

“This manual was developed to support countries in effectively responding to events which may erode the public’s trust in vaccines and the authorities that deliver them,” reads the abstract for the manual.

“It is crucial to be well prepared and have a mechanism in place to respond to vaccine-related events, which may, at any time, evolve into a crisis.” 

Types of events the WHO covers include death after a vaccine, anecdotal stories on social media, critical media reports, and “new critical scientific studies.” 

The guide suggests identifying key audiences so messaging can be effectively tailored. For example, audiences are divided by gender, age, and cultural or religious beliefs.

The manual gives one example of an infant dying from sudden infant death syndrome (SIDS) within 24 hours of being immunized at a local health centre. 

“Preliminary evidence indicates no causal link between the death and the vaccine,” the example reads. 

The WHO tells health agencies to respond by saying the vaccine is safe and effective and should be used to protect people from a given infectious disease.

“Messages should be short, concise, and evidence based.”

The guide further urges governments to maintain good relationships with the media to communicate messaging and “shape the narrative.” 

“Know who will follow the conditions agreed upon and who shows fair and balanced views, and also which media outlets are followed and trusted by your key audiences.”  

Last month, the Public Health Agency of Canada (PHAC) awarded a contract to Pulsar, a social media intelligence firm from the UK. The group will study and analyze “vaccine hesitant” Canadians’ social media comments to determine how to increase vaccine uptake.

“The consultant will analyze vaccine-related conversations, and their participants, on Twitter and social media channels, including Reddit, Blogs, Forums, and News, spanning up to three years of historical data,” reads PHAC’s website.  

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Franchise owners claim they were placed in situations that caused an “irredeemable conflict of interest” after the company Loblaws acquired Shoppers Drug Mart in 2014. 

Alexa Posa

April 19, 2024

Trending News

Yesterday, Canadians across the country took note of rising gas prices and were able to record them rising by up to 22 cents on average in real time as prices shot up from an average of $1.51 per litre to $1.73 in mere seconds.

TCS Wire

April 19, 2024

Trending News

Hundreds of Canadian CEOs, tech leaders, and business owners have penned a letter demanding Trudeau reverse course and stop his abhorrent tax hikes on Canadian businesses.

Keean Bexte

April 19, 2024

Trending News

The feds introduced Canada’s first ever vaccine compensation program in 2020, just before they coerced vaccines into Canadians by threatening their livelihoods, jobs, and EI. 

Mike Campbell

April 18, 2024

Trending News

Budget 2024 has revealed that the Trudeau government is exploring interest-free, Shariah-compliant “halal mortgages” for Muslims looking to buy real estate, and many Canadians aren’t happy about it.

TCS Wire

April 18, 2024

Trending News

“CBC/Radio-Canada is key to our democracy,” reads Budget 2024. And that’s why Trudeau is giving them $42 million for 2024-25 to continue producing “independent” and “high-quality” journalism.

TCS Wire

April 18, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.